Filing Flows

Filing Flows › Xenetic Biosciences (XBIO) › Who owns the stock

Who owns Xenetic Biosciences (XBIO) stock

7 funds reported Xenetic Biosciences (XBIO) shares in their latest 13F filings, worth $443K in all. The largest holder is Renaissance Technologies LLC ($342K). Last quarter 3 funds added to their stakes and 3 cut them.

Largest holders of XBIO (13F)Largest holders of XBIO (13F)Renaissance Technologies LLC$342KGeode Capital Management, LLC$51KVanguard Capital Management LLC$37KJTC Employer Solutions Trustee$8KSBI Securities$3KTower Research Capital LLC$2KMorgan Stanley$437

Largest holders (13F)

FundSharesValueChangeQuarter
Renaissance Technologies LLC117,440$342Kdecrease2026-06-30
Geode Capital Management, LLC17,423$51Kdecrease2026-06-30
Vanguard Capital Management LLC12,681$37Kincrease2026-06-30
JTC Employer Solutions Trustee2,700$8Kunchanged2026-06-30
SBI Securities1,000$3Knew2026-06-30
Tower Research Capital LLC696$2Kdecrease2026-06-30
Morgan Stanley150$437new2026-06-30

Xenetic Biosciences' latest quarter

Xenetic Biosciences, Q2 2026: revenue $661K (+12% year over year), operating margin -147.1%, net loss $930K, operating cash flow −$875K. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most XBIO stock?

By the latest 13F filings: Renaissance Technologies LLC ($342K); Geode Capital Management, LLC ($51K); Vanguard Capital Management LLC ($37K); JTC Employer Solutions Trustee ($8K); SBI Securities ($3K).

What is the short interest in XBIO?

10,961 shares were sold short at the 2026-10-15 settlement, -14.82% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.